November 2024
1. 
   Correction to: Altered expression of caspases-4 and -5 during inflammatory bowel disease and colorectal cancer: Diagnostic and therapeutic potential.
   Clin Exp Immunol. 2024 Nov 28:uxae103. doi: 10.1093.
   

   >> Share

   
   September 2024
2. PAPP D, Korcsmaros T, Hautefort I
   Revolutionizing immune research with organoid-based co-culture and chip systems.
   Clin Exp Immunol. 2024;218:40-54.
   

   >> Share

   
   
3. HUI L, Huang MK, Dai QK, Miao CL, et al
   Amlexanox targeted inhibition of TBK1 regulates immune cell function to exacerbate DSS-induced inflammatory bowel disease.
   Clin Exp Immunol. 2024 Sep 9:uxae082. doi: 10.1093.
   

   >> Share

   
   July 2024
4. SCHNELL A, Aicher C, Schnegelsberg PA, Schwarz B, et al
   Exhausted Lag-3+ CD4+ T cells are increased in pediatric Inflammatory Bowel Disease.
   Clin Exp Immunol. 2024 Jul 24:uxae066. doi: 10.1093.
   

   >> Share

   
   June 2024
5. FANG M, Yao J, Zhang H, Sun J, et al
   Specific deletion of Mettl3 in IECs triggers the development of spontaneous colitis and dysbiosis of T lymphocytes in mice.
   Clin Exp Immunol. 2024;217:57-77.
   

   >> Share

   
   April 2024
6. ESLAMIAN G, Jamee M, Momen T, Rohani P, et al
   Genomic Testing Identifies Monogenic Causes in Patients with Very Early-Onset Inflammatory Bowel Disease: A Multi-center Survey in an Iranian Cohort.
   Clin Exp Immunol. 2024 Apr 23:uxae037. doi: 10.1093.
   

   >> Share

   
   
7. PREUSS B, Frank A, Terjung B, Spengler U, et al
   Autoantibodies to beta tubulin in autoimmune liver diseases-Relation to pANCA and clinical relevance.
   Clin Exp Immunol. 2024;216:146-158.
   

   >> Share

   
   
8. MAO Z, Betti MJ, Cedeno MA, Pedroza LA, et al
   Clinical and cellular phenotypes resulting from a founder mutation in IL10RB.
   Clin Exp Immunol. 2024;216:113-119.
   

   >> Share

   
   March 2024
9. DUARTE-SILVA M, Parra RS, Feitosa MR, Nardini V, et al
   Leukocyte Dysfunction and reduced CTLA-4 Expression are Associated with Perianal Crohn's Disease.
   Clin Exp Immunol. 2024 Mar 22:uxae027. doi: 10.1093.
   

   >> Share

   
   January 2024
10. MORET-TATAY I, Nos P, Iborra M, Rausell F, et al
    Catalase inhibition can modulate the ability of peripheral blood T cells to undergo apoptosis in Crohn's disease.
    Clin Exp Immunol. 2024 Jan 22:uxad134. doi: 10.1093.
    

    >> Share

    
    August 2023
11. DEVAN J, Nosi V, Spagnuolo J, Chancellor A, et al
    Surface protein and functional analyses identify CD4+CD39+ TCR alphabeta+ and activated TCR Vdelta1+ cells with distinct pro-inflammatory functions in Crohn's Disease lesions.
    Clin Exp Immunol. 2023 Aug 16:uxad098. doi: 10.1093.
    

    >> Share

    
    
12. SEIDELIN JB, Jensen S, Hansen M, Bronze MRC, et al
    IAPs and RIPK1 mediate LPS-induced cytokine production in healthy subjects and Crohn's disease.
    Clin Exp Immunol. 2023 Aug 16:uxad092. doi: 10.1093.
    

    >> Share

    
    
13. LUTTER L, Ter Linde JJM, Brand EC, Hoytema van Konijnenburg DP, et al
    Compartment-driven imprinting of intestinal CD4 T cells in inflammatory bowel disease and homeostasis.
    Clin Exp Immunol. 2023 Aug 11:uxad095. doi: 10.1093.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share